Company / R&D Expense
eHealth, Inc. R&D Expense History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$12.4M
FY2025
5-year range
$8.1M / $13.7M
FY2021-FY2025
Trend
-9.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D Expense has fluctuated over the past 10 years, ranging from $7M in FY2020 to $14M in FY2024.
Based on SEC 10-K filings.
$12M in FY2025 with a 10-year CAGR of +2.1%.
Improved from $10M to $12M over the past 2 years.
R&D Expense over time
Growth rates
- 3-Year CAGR
- +10.9%
- 5-Year CAGR
- +12.4%
- 10-Year CAGR
- +2.1%
Key checks
Key Insights
- 5-year CAGR of +12.4%, indicating consistent growth.
- In FY2025, r&d expense decreased 9.5% year-over-year.
- Peak r&d expense was recorded in FY2024.
- Lowest r&d expense in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.98 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $12.4M | -9.5% |
| FY2024 | $13.7M | +31.7% |
| FY2023 | $10.4M | +14.3% |
| FY2022 | $9.1M | +12.3% |
| FY2021 | $8.1M | +17.4% |
| FY2020 | $6.9M | -9.2% |
| FY2019 | $7.6M | -14.6% |
| FY2018 | $8.9M | -26.4% |
| FY2016 | $12.1M | +19.8% |
| FY2015 | $10.1M | +20.2% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026